Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Satsuma Pharmaceuticals to To Present at the Jefferies Virtual Healthcare Conference | |||||||||||
By: GlobeNewswire - 27 May 2020 | Back to overview list |
||||||||||
SOUTH SAN FRANCISCO, Calif., May 27, 2020 (GLOBE NEWSWIRE) -- Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA) a clinical-stage biopharmaceutical company, today announced that John Kollins, President and Chief Executive Officer, is scheduled to present at the Jefferies Virtual Healthcare Conference on Wednesday, June 3, 2020 at 1:00 p.m. Eastern Time. Jefferies Virtual Healthcare Conference
A live audio webcast of the presentation will be accessible on the Events page of the Investors section on the Company’s website at www.satsumarx.com. The webcast replay will be available approximately two hours after the presentation ends and will be accessible for 90 days. About Jefferies Virtual Healthcare Conference For further information, please visit: www.Jefferies.com/Conferences About Satsuma Pharmaceuticals and STS101 Satsuma is headquartered in South San Francisco, California with operations in both California and Research Triangle Park, North Carolina. For further information, please visit www.satsumarx.com INVESTOR AND CORPORATE CONTACTS: Corey Davis, PhD Tom O’Neil, Chief Financial Officer
|
|||||||||||
|
|||||||||||
Copyright 2020 GlobeNewswire | Back to overview list |